CDT
CDT Equity Inc.
NASDAQHealthcareBiotechnologyUS
Rating:B+
Company Profile
CEO
Andrew Regan
IPO Date
2022-03-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
CDT Equity Inc.
CEO
Andrew Regan
IPO Date
2022-03-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 100,000 |
| $1.90 |
| 14 May 2026 | Regan Andrew | director, officer: Chief Executive Officer | C-Conversion | Disposed | 147,401 | $0.00 |
| 30 Apr 2026 | Olsen Ulrik K | director | Disposed | 0 | $0.00 |
| 30 Mar 2026 | Taylor Mark Andrew | 10 percent owner | J-Other | Disposed | 46,902 | $0.00 |
| 30 Mar 2026 | Taylor Mark Andrew | 10 percent owner | J-Other | Acquired | 51,420,358 | $0.00 |
| 30 Mar 2026 | Taylor Mark Andrew | 10 percent owner | J-Other | Disposed | 9,968,931 | $0.00 |
| 30 Mar 2026 | Taylor Mark Andrew | 10 percent owner | J-Other | Disposed | 51,161,318 | $0.00 |
| 30 Mar 2026 | Taylor Mark Andrew | 10 percent owner | Disposed | 0 | $0.00 |
| 30 Mar 2026 | Taylor Mark Andrew | 10 percent owner | Disposed | 0 | $0.00 |